InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Brady Todd C, Chairman & CEO. Officer active across 2 companies, notably Aldeyra Therapeutics, Inc.. In total, 7 reports have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €710k. History available since 30 March 2022. The latest transaction was filed on 3 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Todd C. Brady is the President and CEO of Aldeyra Therapeutics, Inc. He leads the company with a strategic vision focused on innovation and growth. His leadership is essential for navigating a constantly evolving business environment and achieving Aldeyra's objectives.